Adherence to Sorafenib Therapy Is Not Affected by Treatment-Related Side Effects or Demographic Characteristics of Iraqi Patients with Hepatocellular Carcinoma - Egyptian Knowledge Bank - troweb

283685

Adherence to Sorafenib Therapy Is Not Affected by Treatment-Related Side Effects or Demographic Characteristics of Iraqi Patients with Hepatocellular Carcinoma

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

Efficacy and Safety of Sorafenib Versus Supportive Care in Egyptian Advanced Hepatocellular Carcinoma Patients

Article

Patients' Adherence to Capecitabine Treatment Is Affected by The Drug-Related Adverse Effects Rather Than by Their Sociodemographic Characteristics

Article

Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Sorafenib versus Radiotherapy

Article

Exploring Effect of Medication Adherence on Quality of Life among Newly Treated Hepatitis “C” Virus Patients

Article

Exploring Effect of Medication Adherence on Quality of Life among Newly Treated Hepatitis “C” Virus Patients

Article

Factors affecting post-treatment outcomes in patients with hepatocellular carcinoma

Article

Effect of Sorafenib on Liver Biochemistry Prior to Vitamin B17 Coadministration in Ehrlich Ascites Carcinoma Mice Model: Preliminary Phase Study

Article

Treatment Response of Chronic Hepatitis C Patients and Health-Related Quality of Life

Article

IMPACT OF HEPATOCELLULAR CARCINOMA ON HEALTH RELATED QUALITY OF LIFE IN EGYPTIAN PATIENTS: A SINGLE CENTRE STUDY

Article

Outcomes of hepatocellular carcinoma among patients receiving systemic therapy